23andMe’s developer partners recently received an email notifying them that they would no longer have access to customers’ raw genomic data. Timicoin, a blockchain-based healthcare data platform, spoke out about the change.
Cryptocurrency Financial News
23andMe’s developer partners recently received an email notifying them that they would no longer have access to customers’ raw genomic data. Timicoin, a blockchain-based healthcare data platform, spoke out about the change.